These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Grading system and surgical approaches for endolymphatic sac tumors. Li F; Zhang Y; Li W; Wu Q; Kong D; Shi X; Dai C Eur Arch Otorhinolaryngol; 2021 May; 278(5):1345-1353. PubMed ID: 32632613 [TBL] [Abstract][Full Text] [Related]
29. Long experience for the diagnosis and treatment of sporadic endolymphatic sac tumor in a single center. Guo F; Zhang L; Mo L Clin Neurol Neurosurg; 2020 Oct; 197():106078. PubMed ID: 32673897 [TBL] [Abstract][Full Text] [Related]
30. Surgical management of endolymphatic sac tumors. Friedman RA; Hoa M; Brackmann DE J Neurol Surg B Skull Base; 2013 Feb; 74(1):12-9. PubMed ID: 24436884 [TBL] [Abstract][Full Text] [Related]
31. Endolymphatic sac tumors in von Hippel-Lindau disease: report of three cases. Codreanu CM; Duet M; Hautefort C; Wassef M; Guichard JP; Giraud S; Richard S; Roqueplo AP; Tran Ba Huy P Otol Neurotol; 2010 Jun; 31(4):660-4. PubMed ID: 20351605 [TBL] [Abstract][Full Text] [Related]
32. Endolymphatic sac tumors: clinical outcome and management in a series of 9 cases. Timmer FC; Neeskens LJ; van den Hoogen FJ; Slootweg PJ; Dunnebier EA; Pauw BK; Mulder JJ; Cremers CW; Kunst HP Otol Neurotol; 2011 Jun; 32(4):680-5. PubMed ID: 21451430 [TBL] [Abstract][Full Text] [Related]
33. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with analysis of von Hippel-Lindau gene and review. Rao Q; Zhou J; Wang JD; Jin XZ; Ma HH; Lu ZF; Zhou XJ Ann Diagn Pathol; 2010 Oct; 14(5):361-4. PubMed ID: 20850701 [TBL] [Abstract][Full Text] [Related]
34. Endolymphatic sac tumor with overexpression of V2 receptor mRNA and inner ear hydrops. Kitahara T; Maekawa C; Kizawa K; Kamakura T; Horii A; Inohara H Acta Otolaryngol; 2011 Sep; 131(9):951-7. PubMed ID: 21574774 [TBL] [Abstract][Full Text] [Related]
35. Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status. Bambakidis NC; Megerian CA; Ratcheson RA Otol Neurotol; 2004 Sep; 25(5):773-81. PubMed ID: 15354010 [TBL] [Abstract][Full Text] [Related]
36. von Hippel-Lindau disease: deafness due to a non-MRI-visible endolymphatic sac tumor despite targeted screening. Binderup ML; Gimsing S; Kosteljanetz M; Thomsen C; Bisgaard ML Int J Audiol; 2013 Nov; 52(11):771-5. PubMed ID: 24003980 [TBL] [Abstract][Full Text] [Related]
37. Endolymphatic sac tumors in von Hippel-Lindau disease. Lalwani AK Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):857. PubMed ID: 17875849 [No Abstract] [Full Text] [Related]
38. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene. Skalova A; Síma R; Bohus P; Curík R; Lukás J; Michal M Pathol Res Pract; 2008; 204(8):599-606. PubMed ID: 18423895 [TBL] [Abstract][Full Text] [Related]
39. Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel-Lindau syndrome. Nelson T; Hu J; Bannykh S; Fan X; Rudnick J; Vail E CNS Oncol; 2020 Mar; 9(1):CNS50. PubMed ID: 32141326 [TBL] [Abstract][Full Text] [Related]